Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Coeptis Therapeutics Holdings, Inc. - Common Stock (NQ:COEP)

17.00 +0.38 (+2.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,141
Open 16.86
Bid (Size) 16.00 (15)
Ask (Size) 17.34 (2)
Prev. Close 16.62
Today's Range 16.40 - 17.39
52wk Range 2.622 - 19.19
Shares Outstanding 4,820,317
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga

Performance

YTD
+187.6%
+187.6%
1 Month
+32.5%
+32.5%
3 Month
+119.9%
+119.9%
6 Month
+76.4%
+76.4%
1 Year
+415.2%
+415.2%

More News

Read More
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
From Coeptis Therapeutics
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
From Coeptis Therapeutics
Via GlobeNewswire
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
From Coeptis Therapeutics
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
Via Benzinga
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results
Via Benzinga
Topics Stocks
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
From Coeptis Therapeutics
Via GlobeNewswire
COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
From Coeptis Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Monday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Coeptis (NASDAQ: COEP) Accelerates Growth with Strategic Partnerships and Innovation
Via AB Newswire
Topics Artificial Intelligence
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License
Via AB Newswire
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
From Coeptis Therapeutics
Via GlobeNewswire
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
From Coeptis Therapeutics
Via GlobeNewswire

Frequently Asked Questions

Is Coeptis Therapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, Coeptis Therapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does Coeptis Therapeutics Holdings, Inc. - Common Stock trade on?
Coeptis Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock?
The ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock is COEP on the Nasdaq Stock Market
What is the current price of Coeptis Therapeutics Holdings, Inc. - Common Stock?
The current price of Coeptis Therapeutics Holdings, Inc. - Common Stock is 17.00
When was Coeptis Therapeutics Holdings, Inc. - Common Stock last traded?
The last trade of Coeptis Therapeutics Holdings, Inc. - Common Stock was at 10/03/25 04:00 PM ET
What is the market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock?
The market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock is 81.95M
How many shares of Coeptis Therapeutics Holdings, Inc. - Common Stock are outstanding?
Coeptis Therapeutics Holdings, Inc. - Common Stock has 82M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.